Higher Risk of Kidney Failure Associated with Angiotensin Receptor Blockers Versus ACE Inhibitors in Patients with Heart Failure.

Fiche publication

Date publication

mai 2025

Journal

The American journal of medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick

Tous les auteurs :
Moore HJ, Wu WC, Heidenreich PA, Rossignol P, Patel SS, Lu F, Lam PH, Ahmed AA, Faselis C, Butler J, Palant CE, Pitt B, Weir MR, Deedwania P, Atkins D, Raman VK, Rangaswami J, Vargas JD, Zhang S, Morgan CJ, Sheriff HM, Zeng-Treitler Q, Fonarow GC, Ahmed A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40419103

Résumé

Renin-angiotensin system (RAS) inhibition with angiotensin-covering enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) is associated with a lower risk of kidney failure in patients with heart failure. We examined whether this association varies between ACEIs and ARBs.